Related Experiment Video
Updated: Aug 13, 2025

Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction
Published on: February 24, 2014
Multiplex PCR to Streptococcus pneumoniae serotype identification directly in cerebrospinal fluid samples
Mariana Brena de Souza1, Eneas de Carvalho2, Maria Cecília Cergole-Novella1
1Adolfo Lutz Institute, Santo André Regional Center, Av. Ramiro Colleoni, 240 - Vila Dora, Santo André, SP, Zip Code: 09040-160, Brazil.
Abstract:
Streptococcus pneumoniae causes invasive diseases of significant public health concern, such as meningitis. The culture of cerebrospinal fluid (CSF) samples, the standard technique for meningitis diagnoses, is not always positive. Consequently, meaningful information about the etiological agent is lost, which can compromise effective epidemiological surveillance and the improvement of immunization policies. This study aims to standardize a method to genotype pneumococcus in the CSF samples which could mitigate the absence of isolated strains, and also evaluate the prediction of this assay. We applied eight multiplex PCR (mPCR) assays to CSF samples paired with the Quellung reaction applied to the isolated strains. We also compared different master mix kits in the mPCR. Moreover, a retrospective study was conducted with CSF samples considered pneumococcus positive due to the presence of the lytA gene. Results showed that genotyping by the mPCR correlated 100% with the Quellung reaction, and genotyping was dependent on the master mix applied. In the retrospective study (2014-2020), 73.4% were successfully genotyped. The analyses of the receiver operating characteristic curve showed that the cycle threshold (Ct value) around 30 for the lytA gene had a 75% positive chance of successful genotyping, whereas with a Ct value > 35, the chance was 12.5%. Finally, we observed that genotype 19A was prevalent in the period (12%), information unknown until now due to the lack of isolated strains. Therefore, the mPCR of CSF samples can efficiently predict S. pneumoniae serotypes, especially in the absence of isolated strains, which can be a great tool for pneumococcal serotype surveillance.
Insights
Multiplex PCR on cerebrospinal fluid (CSF) samples accurately genotypes Streptococcus pneumoniae, even without isolated strains. This method improves epidemiological surveillance and immunization policy by predicting pneumococcal serotypes, especially genotype 19A.
Area of Science:
- Clinical Microbiology
- Molecular Diagnostics
- Epidemiology
Background:
- Streptococcus pneumoniae causes serious invasive diseases like meningitis.
- Cerebrospinal fluid (CSF) culture, the standard diagnostic, often yields negative results, hindering surveillance and immunization strategies.
- Genotyping pneumococcus directly from CSF could overcome limitations of culture-based methods.
Purpose of the Study:
- To standardize a multiplex PCR (mPCR) method for pneumococcal genotyping directly from CSF samples.
- To evaluate the predictive performance of this mPCR assay.
- To mitigate information loss due to absent bacterial isolates in meningitis diagnostics.
Main Methods:
- Eight multiplex PCR (mPCR) assays were applied to CSF samples.
- mPCR results were compared against the Quellung reaction on isolated strains.
- Different master mix kits were evaluated for mPCR efficiency; a retrospective study analyzed CSF samples positive for the lytA gene.
Main Results:
- mPCR genotyping showed 100% correlation with the Quellung reaction, with performance dependent on the master mix used.
- In a retrospective analysis (2014-2020), 73.4% of CSF samples were successfully genotyped.
- A lytA gene cycle threshold (Ct value) around 30 predicted a 75% chance of successful genotyping, while Ct > 35 predicted only 12.5%.
Conclusions:
- Standardized mPCR of CSF samples is a reliable method for pneumococcal genotyping, especially when isolates are absent.
- The assay effectively predicts Streptococcus pneumoniae serotypes, providing crucial data for surveillance.
- Genotype 19A was identified as prevalent (12%), information previously unavailable, highlighting the assay's value for public health insights.

